Alkermes (NASDAQ:ALKS) Azioni, Quote.MetaTitle.unusual-options

Alkermes

Alkermes PLC

ALKERMES PLC ORD

ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA Pharmaceuticals

Arcellx

ADMA Biologics

Akero Therapeutics

Apogee Therapeutics

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

Caris Life Sciences

Celcuity

Cogent Biosciences

CRISPR Therapeutics

Grifols, S.A. - American Depositary Shares

Grifols

Immunovant

Krystal Biotech

Kymera Therapeutics

Legend Biotech Corporation - American Depositary Shares

Legend Biotech

Merus

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co

Nuvalent

Vaxcyte

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

PTC Therapeutics

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

TG Therapeutics

Viking Therapeutics

Alkermes (ALKS) Previsione

Utili

Guidance

Vendite allo scoperto

Rapporto azionario

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Comments

Alkermes Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO